Related Experiment Videos
Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients
Verena Pihusch1, Andreas Rank, Ruth Steber
1Medizinische Klinik III, Grosshadern, Klinikum der Ludwig Maximilians, Universitaet Muenchen, Germany. verana.pihusch@t-online.de
Transplantation
|May 30, 2006
Summary
Endothelial cell derived microparticles (EMP) increase significantly during acute graft-versus-host disease (aGVHD) after hematopoietic stem cell transplantation. Elevated EMP may indicate endothelial cell injury and aid in early aGVHD diagnosis.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Microparticle alterations are linked to inflammatory and hemostatic disorders.
- Endothelial cell-derived microparticles (EMP) are implicated in various disease states.
Purpose of the Study:
- To investigate EMP levels in hematopoietic stem cell transplant (HSCT) recipients.
- To determine if EMP can serve as a biomarker for acute graft-versus-host disease (aGVHD).
Main Methods:
- Prospective analysis of EMP in 19 HSCT recipients.
- Flow cytometry (FACS) used to detect EMP via CD62 and annexin V.
- Human umbilical vein endothelial cells (HUVEC) stimulated with TNF-alpha used as positive controls.
Main Results:
- EMP levels were not significantly affected by conditioning regimens.
- Significantly higher EMP levels were observed during aGVHD compared to patients without aGVHD (P = 0.004).
- Infectious complications and immunosuppressive therapy showed no significant impact or a trend towards elevated EMP, respectively.
Conclusions:
- Elevated EMP during aGVHD suggests endothelial cell injury.
- EMP may serve as a diagnostic marker for early aGVHD differentiation from other transplant-related complications.